344 related articles for article (PubMed ID: 12931249)
1. Allogeneic HSCT for autoimmune diseases: conventional conditioning regimens.
Nash RA
Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S77-80. PubMed ID: 12931249
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic stem cell transplantation for autoimmune diseases: nonmyeloablative conditioning regimens.
Oyama Y; Traynor AE; Barr W; Burt RK
Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S81-3. PubMed ID: 12931250
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic stem cell transplantation in the new millennium: report from City of Hope National Medical Center.
Molina A; Popplewell L; Kashyap A; Nademanee A
Clin Transpl; 2000; ():317-42. PubMed ID: 11512326
[TBL] [Abstract][Full Text] [Related]
4. The rationale behind autologous autoimmune hematopoietic stem cell transplant conditioning regimens: concerns over the use of total-body irradiation in systemic sclerosis.
Burt RK; Patel D; Thomas J; Yeager A; Traynor A; Heipe F; Arnold R; Marmont A; Collier D; Glatstein E; Snowden J
Bone Marrow Transplant; 2004 Nov; 34(9):745-51. PubMed ID: 15361910
[TBL] [Abstract][Full Text] [Related]
5. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
Liu QF; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
[TBL] [Abstract][Full Text] [Related]
6. [Second allogeneic transplant for leukemia relapsed after first allogeneic transplantation].
Yang DL; Han MZ; Feng SZ; Wang M; Zou DH; Wei JL; Yan ZS; Zhou SY; Liu QG; Jiang EL; Huang Y; Wang HH; Zhou Z; Zhai WJ; Yan WW; Han ZC
Zhonghua Xue Ye Xue Za Zhi; 2004 May; 25(5):285-9. PubMed ID: 15182537
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic efficacy of hematopoietic stem cell transplantation in patients with chronic myelogenous leukemia].
Liu QF; Fan ZP; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1227-9, 1241. PubMed ID: 15567763
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission].
Wang HH; Feng SZ; Wang M; Wei JL; Jiang EL; Zhang L; Huang Y; Zhou SY; Liu QG; Qiu LG; Han MZ; Yan WW
Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):389-92. PubMed ID: 15355688
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of unrelated cord blood transplants and allogeneic-related hematopoietic stem cell transplants in children with high-risk acute lymphocytic leukemia.
Jacobsohn DA; Hewlett B; Ranalli M; Seshadri R; Duerst R; Kletzel M
Bone Marrow Transplant; 2004 Nov; 34(10):901-7. PubMed ID: 15361908
[TBL] [Abstract][Full Text] [Related]
10. Future strategies in hematopoietic stem cell transplantation for rheumatoid arthritis.
Burt RK; Barr W; Oyama Y; Traynor A; Slavin S
J Rheumatol Suppl; 2001 Oct; 64():42-8. PubMed ID: 11642504
[TBL] [Abstract][Full Text] [Related]
11. [Effects of allogeneic hematopoietic stem cell transplantation with very-high-dose conditioning regimen for refractory leukemia].
Liu QF; Sun J; Xu D; Zhang Y; Fan ZP; Wei YQ; Meng FY; Zhou SY
Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1117-9. PubMed ID: 15485779
[TBL] [Abstract][Full Text] [Related]
12. Nonmyeloablative allogeneic stem cell transplantation (NST) after truly nonmyeloablative and reduced intensity conditioning regimens.
Banna GL; Aversa S; Sileni VC; Favaretto A; Ghiotto C; Monfardini S
Crit Rev Oncol Hematol; 2004 Sep; 51(3):171-89. PubMed ID: 15331077
[TBL] [Abstract][Full Text] [Related]
13. Haematopoetic stem cell transplantation for refractory autoimmune cytopenia.
Passweg JR; Rabusin M; Musso M; Beguin Y; Cesaro S; Ehninger G; Espigado I; Iriondo A; Jost L; Koza V; Lenhoff S; Lisukov I; Locatelli F; Marmont A; Philippe P; Pilatrino C; Quartier P; Stary J; Veys P; Vormoor J; Wahlin A; Zintl F; Bocelli-Tyndall C; Tyndall A; Gratwohl A;
Br J Haematol; 2004 Jun; 125(6):749-55. PubMed ID: 15180864
[TBL] [Abstract][Full Text] [Related]
14. Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases.
Hinterberger W; Hinterberger-Fischer M; Marmont A
Bone Marrow Transplant; 2002 Dec; 30(11):753-9. PubMed ID: 12439698
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo expanded allogeneic cord blood progenitor cell transplantation with a non-myeloablative conditioning regimen would cure autoimmune diseases.
Sastry PS
Med Hypotheses; 2000 Mar; 54(3):423-4. PubMed ID: 10783478
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic stem cell transplantation in patients with severe Langerhans cell histiocytosis and hematological dysfunction: experience of the French Langerhans Cell Study Group.
Akkari V; Donadieu J; Piguet C; Bordigoni P; Michel G; Blanche S; Casanova JL; Thomas C; Vilmer E; Fischer A; Bertrand Y;
Bone Marrow Transplant; 2003 Jun; 31(12):1097-103. PubMed ID: 12796789
[TBL] [Abstract][Full Text] [Related]
17. Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation.
Bacigalupo A; Sormani MP; Lamparelli T; Gualandi F; Occhini D; Bregante S; Raiola AM; di Grazia C; Dominietto A; Tedone E; Piaggio G; Podesta M; Bruno B; Oneto R; Lombardi A; Frassoni F; Rolla D; Rollandi G; Viscoli C; Ferro C; Garbarino L; Van Lint MT
Haematologica; 2004 Oct; 89(10):1238-47. PubMed ID: 15477210
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic hematopoietic stem cell transplantation in a patient affected by large granular lymphocyte leukemia and multiple sclerosis.
La Nasa G; Littera R; Cocco E; Battistini L; Marrosu MG; Contu L
Ann Hematol; 2004 Jun; 83(6):403-5. PubMed ID: 14648027
[TBL] [Abstract][Full Text] [Related]
19. Nonmyeloablative stem cell transplantation: lessons from the first decade of clinical experience.
Shimoni A; Nagler A
Curr Hematol Rep; 2004 Jul; 3(4):242-8. PubMed ID: 15217553
[TBL] [Abstract][Full Text] [Related]
20. A new minimally ablative stem cell transplantation procedure in high-risk patients not eligible for nonmyeloablative allogeneic bone marrow transplantation.
Shapira MY; Or R; Resnick IB; Bitan M; Ackerstein A; Samuel S; Elad S; Zilberman I; Miron S; Slavin S
Bone Marrow Transplant; 2003 Sep; 32(6):557-61. PubMed ID: 12953126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
